Skip to content

Clinical outcomes following two different bone grafting techniques with simultaneous implant placement: A randomized controlled trial

Clinical outcomes following two different bone grafting techniques with simultaneous implant placement: A randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260212006
Enrollment
24
Registered
2026-02-12
Start date
2025-11-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Horizontal alveolar ridge deficiency in posterior edentulous area requiring dental implant Horizontal ridge augmentation Guided bone regeneration Sticky bone Autologous fibrin glue Concentrated growth factor Transmucosal healing Simultaneous implant placement

Interventions

Participants receive one-stage implant placement with simultaneous transmucosal guided bone regeneration. After implant placement at crestal level and connection to healing abutment, particulate bovin
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery
Transmucosal GBR with membrane,Sticky bone graft without membrane

Sponsors

Faculty of Dentistry Srinakharinwirot University
Lead Sponsor
Geistlich
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Individuals of both genders aged 20 years or older who requiring dental implant placement 2. Categorized as ASA classification I or II 3. Edentulous area requiring 1 dental implant located in the premolar and molar area of either maxilla or mandible 4. Healed ridge for at least 3 months after tooth extraction. 5. Adequate keratinized tissue width (at least 2 mm) 6. Presence of minimal self-contained horizontal ridge defect, characterized by buccal bone thickness less than 2 mm or exposed implant threads up to 2 mm after implant placement

Exclusion criteria

Exclusion criteria: 1. Patients with systemic diseases or conditions that would interfere with osseointegration and bone healing process such as osteoporosis 2. Patients with a history of head and neck radiation therapy or chemotherapy 3. Patients who have received IV bisphosphonate/oral bisphosphonate, immunosuppressants, and antiresorptive medications 4. Patients with hematologic disorders or coagulation abnormalities 5. Patients with uncontrolled cardiovascular disease or diabetes 6. Patients diagnosed with severe psychotic disorder 7. Patients with uncontrolled periodontitis 8. Patients with poor oral hygiene, defined as OHI-S score 3.1-6.0 9. Patients with history of smoking 10. Patients with history of parafunctional habits (e.g., bruxism). 11. Patients who are heavy alcohol drinkers (exceeding 7 drinks per week for women or 14 drinks per week for men) 12. Patients who are pregnant or currently breastfeeding 13. Patients with poor bone density, classified as D4 according to Misch classification 14. Primary stability of the inserted implant, defined as a torque value below 30 Ncm

Design outcomes

Primary

MeasureTime frame
Horizontal bone gain 4 months after surgery Linear measurement of ridge width in millimeters using CBCT at standardized reference points

Secondary

MeasureTime frame
Vertical bone gain 4 months after surgery Linear measurement of ridge height in millimeters using CBCT at standardized reference point,Postoperative complications 1 week to 4 months after surgery Clinical assessment of infection, membrane exposure, graft loss and wound dehiscence

Countries

Thailand

Contacts

Public ContactChanchai Wongchuensoontorn

Srinakharinwirot University

chanchaiwong@yahoo.com026495000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026